Canvas Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$237K Buy
655
+33
+5% +$11.3K 0.03% 225
2026
Q1
$219K Buy
+622
New +$222K 0.04% 226
2021
Q4
Sell
-963
Closed -$205K 135
2021
Q3
$205K Buy
+963
New +$222K 0.08% 114

Other funds holding AMGN

Canvas Wealth Advisors's AMGN Position: Q2 2026 in Review

Canvas Wealth Advisors increased its Amgen (AMGN) stake by 5.3% in Q2 2026, buying an estimated $11.3K and bringing the position to 655 shares worth $237K. The position accounts for 0.03% of the portfolio, ranked #225.

Canvas Wealth Advisors first reported a position in AMGN in Q3 2021 and has held it in 3 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Canvas Wealth Advisors held 655 shares of Amgen worth $237K as of Q2 2026.
  • Canvas Wealth Advisors bought 33 Amgen shares in Q2 2026, an estimated $11.3K.
  • Amgen made up 0.03% of Canvas Wealth Advisors's portfolio in Q2 2026, its #225 holding.
  • Canvas Wealth Advisors first reported a position in Amgen in Q3 2021 and has held it in 3 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Canvas Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.